Microbiology & Virology

“Superbug spreading undetected”

A superbug resistant to all known antibiotics is spreading undetected through hospital wards across the world, it is claimed.

British Journal of Biomedical Science Issue 4 2018: a synopsis

The hard copy of the autumn issue of our journal is complete. Editor Andrew Blann outlines the content of the latest issue, which includes six papers that use techniques in molecular genetics.

Sniffing out cancer

Claire Guest, Co-founder of Medical Detection Dogs, explains how canines could have an important role in discovering disease.

Treating clostridium difficile infection

Emmanuel Nwankwo and Andrew Ward ask whether empirical antibiotic therapy can still be relied upon.

Group b strep awareness

The IBMS supported Group B Strep Awareness Month, highlighting the vital role biomedical scientists play in identifying the bacterium that can cause a potentially deadly infection in newborns.

Olympus driving research forward

With expanded imaging capabilities, Olympus has launched version 2.1 of its imaging platform cellSens.

Measurement software upgrade

Synbiosis’ eAST software for automatic zone measurement of antimicrobial susceptibility testing (AST) plates has been upgraded to improve antibiotic SIR (Susceptible, Intermediate, Resistant) category determination.

Bacteria provoke “warfare”

Some bacteria can release toxins that provoke their neighbours into attacking each other, says a new study.

First Keystone human infection

Keystone virus has made the jump from mosquitoes to humans, with a case now confirmed in Florida.

Rapid molecular methods in clinical microbiology

Microbiologist Mark Wilks highlights the potential rapid molecular methods presented in the recent conference of the British Society for Microbial Technology.

Fast molecular diagnostics for tight turnaround times

Turnaround times for diagnostic tests can be an obstacle to effectively controlling healthcare associated infections (HAI), such as methicillin-resistant Staphylococcus aureus (MRSA) and carbapenemase producing Enterobacteriaceae (CPE), with delayed results leading to ward closures and cancelled operations.

Top